Articles

For patients with severe hypertension that remains uncontrolled despite medical therapy, radiofrequency (RF) energy can be used in the renal vessels to block nerves involved with the sympathetic...

September 17, 2010 – The U.S. Food and Drug Administration (FDA) today expanded the indication for three cardiac resynchronization therapy defibrillators (CRT-D) to all classes of heart failure...

Following cath lab procedures, the final step is to attain hemostasis at the arteriotomy access site. Manual compression has been the gold standard for decades, but vascular closure devices (VCDs...

September 1, 2010 – A new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic...

August 19, 2010 – Researchers at the University of Maryland School of Medicine in Baltimore have developed a novel 3-D imaging approach that may improve the accuracy of treatment for ventricular...

Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently been the topic of numerous medical and nonmedical publications.

Early defibrillation is often referred to as the “critical link in the chain of survival,” according to the American Heart Association (AHA). But even in a hospital setting, the time from when a...

New U.S. Food and Drug Administration (FDA) indications for two key heart failure device therapies may help improve survival, slow the progress of the disease and, in some cases, reverse its...

Monitoring congestive heart failure patients for any worsening in their condition is based mainly on patient compliance to accurately weigh themselves every day and report any unusual symptoms.

Intracardiac echocardiography (ICE) offers a clearer view of transcatheter devices and electrophysiology (EP) procedures from inside the heart.